Publication: Formulary Journal

First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Antibiotics following gallbladder surgery unnecessary: Study

Postoperative antibiotics after cholecystectomy (gallbladder surgery) do not reduce the risk of infection, according to a study published in the Journal of the American Medical Association .Lead author Jean-Marc Regimbeau, MD, PhD, of CHU Nord Amiens ... [Published Formulary Journal - Jul 10 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Maintaining normal waist circumference can help prevent COPD

Individuals with a large waist circumference may face a higher risk of developing chronic obstructive pulmonary disease (COPD), according to a study published July 7 in CMAJ (Canadian Medical Association Journal) .Lead researcher Gundula Behrens, PhD, ... [Published Formulary Journal - Jul 10 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

Study: Childhood vaccines are safe, low risk

There are some risks associated with some childhood vaccinations, but overall the evidence shows that vaccines are very safe, according a study published in the July 1 online edition and the August print issue of Pediatrics .The study, "Safety of Vaccines ... [Published Formulary Journal - Jul 07 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Study: Lifestyle factors play a role in statin med adherence

Lifestyle factors may help predict whether people will adhere to statin therapy for high cholesterol, according to a study published in  CMAJ  ( Canadian Medical Association Journal ).Heli Halava, departments of public health and pharmacology, University ... [Published Formulary Journal - Jun 26 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Docetaxel (Taxotere): Possible symptoms of alcohol intoxication

FDA released a warning about the  potential side effect of intoxication or a feeling of being drunk that can occur with the administration of the intravenous chemotherapy drug docetaxol (Taxotere), which contains ethanol (alcohol).The alcohol content ... [Published Formulary Journal - Jun 26 2014]
First reported Jun 24 2014 - Updated Jun 24 2014 - 1 reports

Testosterone products: FDA requires beefed up labeling to include risk of VTE, including DVT, PE

FDA is requiring manufacturers of all approved testosterone products to include a warning in the drug labeling about the risk of blood clots in the veins, also known as venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism ... [Published Formulary Journal - Jun 24 2014]
First reported Jun 23 2014 - Updated Jun 23 2014 - 1 reports

FDA antidepressant warnings may have led to more teen suicide attempts: Study

Teen suicide attempts went up about 22% after FDA warned about dangers of antidepressants, according to a study published in the June 18 BMJ, and reported by HealthDay News .Lead author Christine Lu, an instructor in population medicine at the Harvard ... [Published Formulary Journal - Jun 23 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

Study: Topiramate XR improves seizure control in epilepsy patients

An extended-release formulation of topiramate (Qudexy XR, Upsher-Smith Laboratories ) has been shown to be sale and effective in refractory epilepsy patients in a global phase 3 clinical trial.The results were published in the June issue of Epilepsia ... [Published Formulary Journal - Jun 20 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

SSRIs in pregnancy not linked to cardiac defects in babies

In pregnancy, first trimester use of antidepressants does not substantively increase the risk of specific cardiac defects in babies, and should not be an important consideration in the treatment decision, according to a study published in the June 19 ... [Published Formulary Journal - Jun 20 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

ADA: Study says non-insulin dulaglutide demonstrates effective blood glucose control in diabetes patients

Some patients with type 2 diabetes reach a point where oral therapy alone may no longer be effective enough. In these cases, healthcare professionals may choose to intensify treatment with an injectable.Data from Eli Lilly and Company , released at the ... [Published Formulary Journal - Jun 20 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

ADA: Empagliflozin versus placebo controlled patients with type 2 diabetes on multiple daily insulin injections

In a 52-week study of obese adults with type 2 diabetes on high insulin doses with or without metformin, adding empagliflozin to multiple daily insulin injections significantly reduced blood glucose and body weight with lower insulin doses compared with ... [Published Formulary Journal - Jun 20 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

ADA: Empagliflozin added to metformin showed greater reductions in blood glucose, body weight versus glimepiride

In a 2-year study, empagliflozin as add-on to metformin demonstrated significantly greater decreases in hemoglobin A 1c (a measure of average blood glucose over the past 2 to 3 months), body weight and blood pressure compared with glimepiride as add-on ... [Published Formulary Journal - Jun 20 2014]

Quotes

The study, "Safety of Vaccines Used for Routine Immunization of U S Children: A Systematic Review" is part of a larger report on the safety of vaccines for adults, adolescents and children funded by the Agency for Healthcare Research and Quality...

More Content

All (17) | News (17) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Maintaining normal waist circumference can help... [Published Formulary Journal - Jul 10 2014]
Antibiotics following gallbladder surgery unnec... [Published Formulary Journal - Jul 10 2014]
Study: Childhood vaccines are safe, low risk [Published Formulary Journal - Jul 07 2014]
Study: Lifestyle factors play a role in statin ... [Published Formulary Journal - Jun 26 2014]
Docetaxel (Taxotere): Possible symptoms of alco... [Published Formulary Journal - Jun 26 2014]
Testosterone products: FDA requires beefed up l... [Published Formulary Journal - Jun 24 2014]
FDA antidepressant warnings may have led to mor... [Published Formulary Journal - Jun 23 2014]
Study: Topiramate XR improves seizure control i... [Published Formulary Journal - Jun 20 2014]
SSRIs in pregnancy not linked to cardiac defect... [Published Formulary Journal - Jun 20 2014]
ADA: Study says non-insulin dulaglutide demonst... [Published Formulary Journal - Jun 20 2014]
ADA: Studies point to safety, efficacy profile ... [Published Formulary Journal - Jun 20 2014]
ADA: Empagliflozin versus placebo controlled pa... [Published Formulary Journal - Jun 20 2014]
ADA: Empagliflozin added to metformin showed gr... [Published Formulary Journal - Jun 20 2014]
EULAR: Sarilumab investigational anti-IL-6R the... [Published Formulary Journal - Jun 19 2014]
ADA: Canola oil can help control blood glucose ... [Published Formulary Journal - Jun 17 2014]
Is a Hep C drug price war headed our way? [Published Formulary Journal - Jun 16 2014]
Joint Commission raises awareness of unsafe inj... [Published Formulary Journal - Jun 16 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.